Adam Dainey
Head of Investor Relations
Replay available
NovoCure Limited (NVCR) Q2 2026 Earnings Call
NovoCure Limited (NASDAQ: NVCR) Q2 2026 earnings conference call, held 2026-07-23. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Bill Doyle
Executive Chairman
Frank Leonard
Chief Executive Officer
Uri Weinberg
Chief Innovation and Medical Officer
Christoph Brackmann
Chief Financial Officer
Ajay Kumar
Analyst, Evercore
Jason Bittnor
Analyst, Piper Sandler
Larry Beagleson
Analyst, Wells Fargo
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Novocure Limited.
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:04.494 Good day and welcome to NovoCure's second quarter 2026 earnings call. 00:00:04.494 -- 00:00:07.516 At this time, all participants are in listen-only mode. 00:00:07.516 -- 00:00:11.038 After the speaker's presentation, there will be a question and answer session. 00:00:11.038 -- 00:00:15.201 To ask a question, you will need to press star 1-1 on your touchtone telephone. 00:00:15.201 -- 00:00:19.704 Please note this call is being recorded. I would like to turn the call over to Adam Dainey, 00:00:19.704 -- 00:00:23.685 Head of Investor Relations. Please go ahead. 00:00:45.770 -- 00:00:49.112 Good morning. Good morning. Thank you. And thank you for joining us to review NovoCure's 00:00:49.112 -- 00:00:54.234 second quarter 2026 performance. I'm joined on the phone today by our Executive Chairman 00:00:54.234 -- 00:00:59.857 Bill Doyle, CEO Frank Leonard, Chief Innovation and Medical Officer Uri Weinberg, 00:00:59.857 -- 00:01:04.839 and CFO Christoph Brackmann. For your reference, slides accompanying this earnings release 00:01:04.839 -- 00:01:08.720 can be found on our website, www.novocure.com, 00:01:08.901 -- 00:01:13.005 on the Investor Relations page under Quarterly Results. 00:01:13.005 -- 00:01:16.226 Before we start, I would like to remind you that our discussions during this conference 00:01:16.226 -- 00:01:20.068 call will include forward-looking statements and actual results could differ materially 00:01:20.068 -- 00:01:24.170 from those projected in these statements. These statements involve a number of risks 00:01:24.170 -- 00:01:28.132 and uncertainties, some of which are beyond our control and are described from time to 00:01:28.132 -- 00:01:33.494 time in our SEC filings. We do not intend to update publicly any forward-...